Placental ferroptosis in preeclampsia: An integrative and comprehensive review

Tamir Edri1, Sapir Lianski1, Sarah M Cohen1

  • 1Obstetrics & Gynecology Division, Hadassah Medical Center, Faculty of Medicine of the Hebrew University of Jerusalem, Jerusalem, Israel.

PubMed

Insights

Ferroptosis, a form of cell death involving lipid peroxidation, is increasingly linked to preeclampsia. This review explores ferroptosis

Area of Science:

  • Reproductive biology and medicine
  • Cellular pathology
  • Biochemistry

Background:

  • Preeclampsia is a significant cause of maternal and perinatal complications.
  • Ferroptosis, a regulated cell death pathway, is implicated in preeclampsia's pathophysiology.
  • Placental dysfunction is a key feature of preeclampsia.

Purpose of the Study:

  • To review the evidence linking ferroptosis to placental dysfunction in preeclampsia.
  • To explore the biochemical mechanisms underlying ferroptosis in the syncytiotrophoblast.
  • To discuss the therapeutic potential of targeting ferroptosis for preeclampsia treatment.

Main Methods:

  • Synthesis of current scientific literature on ferroptosis and preeclampsia.
  • Detailed review of biochemical pathways involved in ferroptosis (e.g., iron metabolism, lipid peroxidation, glutathione-GPX4).
  • Analysis of emerging data on systemic manifestations and therapeutic strategies.

Main Results:

  • Disrupted iron metabolism, oxidative stress, and impaired antioxidant defenses promote ferroptosis in placental cells.
  • Ferroptosis contributes to syncytiotrophoblast damage and placental dysfunction.
  • Placental ferroptosis may drive systemic maternal complications via sFlt-1 release and endothelial injury.

Conclusions:

  • Ferroptosis is a critical mechanism in preeclampsia pathogenesis.
  • Targeting ferroptosis offers promising therapeutic avenues for preeclampsia.
  • Ferroptosis provides a unifying framework for understanding and treating preeclampsia.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
3.5K